BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28734777)

  • 1. Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs.
    Krout D; Pramod AB; Dahal RA; Tomlinson MJ; Sharma B; Foster JD; Zou MF; Boatang C; Newman AH; Lever JR; Vaughan RA; Henry LK
    Biochem Pharmacol; 2017 Oct; 142():204-215. PubMed ID: 28734777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites.
    Parnas ML; Gaffaney JD; Zou MF; Lever JR; Newman AH; Vaughan RA
    Mol Pharmacol; 2008 Apr; 73(4):1141-50. PubMed ID: 18216182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.
    Dahal RA; Pramod AB; Sharma B; Krout D; Foster JD; Cha JH; Cao J; Newman AH; Lever JR; Vaughan RA; Henry LK
    J Biol Chem; 2014 Oct; 289(43):29712-27. PubMed ID: 25179220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential binding of tropane-based photoaffinity ligands on the dopamine transporter.
    Vaughan RA; Agoston GE; Lever JR; Newman AH
    J Neurosci; 1999 Jan; 19(2):630-6. PubMed ID: 9880583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the benztropine analog [
    Tomlinson MJ; Krout D; Pramod AB; Lever JR; Newman AH; Henry LK; Vaughan RA
    Neurochem Int; 2019 Feb; 123():34-45. PubMed ID: 30125594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tropane-based irreversible ligands for the dopamine transporter.
    Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH
    J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of dopamine transporter oligomers after copper linking.
    Zhen J; Reith MEA
    J Neurochem; 2018 Jan; 144(2):162-171. PubMed ID: 29168892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of cocaine analog [125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter.
    Vaughan RA; Sakrikar DS; Parnas ML; Adkins S; Foster JD; Duval RA; Lever JR; Kulkarni SS; Hauck-Newman A
    J Biol Chem; 2007 Mar; 282(12):8915-25. PubMed ID: 17255098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2beta-carbomethoxy-3beta-biphenyltropane.
    Newman AH; Cha JH; Cao J; Kopajtic T; Katz JL; Parnas ML; Vaughan R; Lever JR
    J Med Chem; 2006 Nov; 49(22):6621-5. PubMed ID: 17064081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113.
    Hill ER; Huang X; Zhan CG; Ivy Carroll F; Gu HH
    Neuropharmacology; 2011; 61(1-2):112-20. PubMed ID: 21420984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodinated azide and isothiocyanate derivatives of cocaine for irreversible labeling of dopamine transporters: synthesis and covalent binding studies.
    Lever JR; Zou MF; Parnas ML; Duval RA; Wirtz SE; Justice JB; Vaughan RA; Newman AH
    Bioconjug Chem; 2005; 16(3):644-9. PubMed ID: 15898733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
    Chen N; Zhen J; Reith ME
    J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual incorporation of photoaffinity ligands on dopamine transporters implicates proximity of labeled domains.
    Vaughan RA; Gaffaney JD; Lever JR; Reith ME; Dutta AK
    Mol Pharmacol; 2001 May; 59(5):1157-64. PubMed ID: 11306699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Aryl-2-(3'-substituted-1',2',4'-oxadiazol-5'-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters.
    Carroll FI; Gray JL; Abraham P; Kuzemko MA; Lewin AH; Boja JW; Kuhar MJ
    J Med Chem; 1993 Oct; 36(20):2886-90. PubMed ID: 8411004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
    Chen N; Vaughan RA; Reith ME
    J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
    Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
    J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.